Palbociclib to reverse endocrine resistance in breast cancer: a TREnd in the right direction?
Oncotarget
.
2018 Sep 25;9(75):34031-34032.
doi: 10.18632/oncotarget.26133.
Authors
Amelia McCartney
1
,
Angelo Di Leo
1
,
Luca Malorni
1
Affiliation
1
Luca Malorni: Sandro Pitigliani Medical Oncology Department, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy; Translational Research Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy.
PMID:
30344918
PMCID:
PMC6183349
DOI:
10.18632/oncotarget.26133
No abstract available
Keywords:
CDK4/6 inhibitors; breast cancer; endocrine resistance; metastatic; palbociclib.
Publication types
Editorial